TrialBritish journal of clinical pharmacology2025

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study.

Yuhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.